1 |
Abenavoli, L., Capasso, R., Milic, N. and Capasso, F. (2010) Milk thistle in liver diseases: past, present, future. Phytother. Res. 24, 1423-1432.
DOI
|
2 |
Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. (1997) -catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804.
DOI
|
3 |
Ahnen, D. J., Wade, S. W., Jones, W. F., Sifri, R., Mendoza Silveiras, J., Greenamyer, J., Guiffre, S., Axilbund, J., Spiegel, A. and You, Y. N. (2014) The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin. Proc. 89, 216-224.
DOI
|
4 |
Amado, N. G., Fonseca, B. F., Cerqueira, D. M., Neto, V. M. and Abreu, J. G. (2011) Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci. 89, 545-554.
DOI
|
5 |
Anderson, E. C., Hessman, C., Levin, T. G., Monroe, M. M. and Wong, M. H. (2011) The role of colorectal cancer stem cells in metastatic disease and therapeutic response. Cancers (Basel) 3, 319-339.
DOI
|
6 |
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. (1996) Functional interaction of bcatenin with the transcription factor LEF-1. Nature 382, 638-642.
DOI
|
7 |
Bos, J. L., Fearon, E. R., Hamilton, S. R., Verlaan-de Vries, M., van Boom, J. H., van der Eb, A. J. and Vogelstein, B. (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327, 293-297.
DOI
|
8 |
Cassileth, B. R. and Deng, G. (2004) Complementary and alternative therapies for cancer. Oncologist 9, 80-89.
DOI
|
9 |
Chastek, B., Kulakodlu, M., Valluri, S. and Seal, B. (2013) Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization. Postgrad. Med. 125, 73-82.
|
10 |
Cufi, S., Bonavia, R., Vazquez-Martin, A., Corominas-Faja, B., Oliveras-Ferraros, C., Cuyas, E., Martin-Castillo, B., Barrajon-Catalan, E., Visa, J., Segura-Carretero, A., Bosch-Barrera, J., Joven, J., Micol, V. and Menendez, J. A. (2013) Silibinin meglumine, a watersoluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells. Food Chem. Toxicol. 60, 360-368.
DOI
|
11 |
Eo, H. J., Park, G. H., Song, H. M., Lee, J. W., Kim, M. K., Lee, M. H., Lee, J. R., Koo, J. S. and Jeong, J. B. (2015) Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. Int. Immunopharmacol. 24, 1-6.
DOI
|
12 |
Espada, J., Calvo, M. B., Diaz-Prado, S. and Medina, V. (2009) Wnt signalling and cancer stem cells. Clin. Transl. Oncol. 11, 411-427.
DOI
|
13 |
Fearon, E. R., Hamilton, S. R. and Vogelstein, B. (1987) Clonal analysis of human colorectal tumors. Science 238, 193-197.
DOI
|
14 |
Fodde, R., Smits, R. and Clevers, H. (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1, 55-67.
DOI
|
15 |
Kwon, I. K., Wang, R., Thangaraju, M., Shuang, H., Liu, K., Dashwood, R., Dulin, N., Ganapathy, V. and Browning, D. D. (2010) PKG inhibits TCF signaling in colon cancer cells by blocking -catenin expression and activating FOXO4. Oncogene 29, 3423-3434.
DOI
|
16 |
Hawcroft, G., D'Amico, M., Albanese, C., Markham, A. F., Pestell, R. G. and Hull, M. A. (2002) Indomethacin induces differential expression of -catenin, -catenin and T-cell factor target genes in human colorectal cancer cells. Carcinogenesis 23, 107-114.
DOI
|
17 |
Herbst, A. and Kolligs, F. T. (2007) Wnt signaling as a therapeutic target for cancer. Methods Mol. Biol. 361, 63-91.
|
18 |
Kaur, M., Velmurugan, B., Tyagi, A., Agarwal, C., Singh, R. P. and Agarwal, R. (2010). Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through downregulation of -catenin-dependent signaling. Neoplasia 12, 415-424.
DOI
|
19 |
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G. H., Tan, Y., Zhang, Z., Lin, X. and He, X. (2002). Control of -catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847.
DOI
|
20 |
Lu, W., Lin, C., King, T. D., Chen, H., Reynolds, R. C. and Li, Y. (2012) Silibinin inhibits Wnt/-catenin signaling by suppressing Wnt coreceptor LRP6 expression in human prostate and breast cancer cells. Cell. Signal. 24, 2291-2296.
DOI
|
21 |
Luu, H. H., Zhang, R., Haydon, R. C., Rayburn, E., Kang, Q., Si, W., Park, J. K., Wang, H., Peng, Y., Jiang, W. and He, T. C. (2004) Wnt/-catenin signaling pathway as a novel cancer drug target. Curr. Cancer Drug Targets 4, 653-671.
DOI
|
22 |
Novo, M. C., Osugui, L., dos Reis, V. O., Longo-Maugeri, I. M., Mariano, M. and Popi, A. F. (2015) Blockage of Wnt/-catenin signaling by quercetin reduces survival and proliferation of B-1 cells in vitro. Immunobiology 220, 60-67.
DOI
|
23 |
Mereish, K. A., Bunner, D. L., Ragland, D. R. and Creasia, D. A. (1991) Protection against microcystin-LR-induced hepatotoxicity by Silymarin:biochemistry, histopathology, and lethality. Pharm. Res. 8, 273-277.
DOI
|
24 |
Narayan, S. (2004) Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting -cateninmediated transactivation and cell-cell adhesion pathways. J. Mol. Histol. 35, 301-307.
|
25 |
Neergheen, V. S., Bahorun, T., Taylor, E. W., Jen, L. S. and Aruoma, O. I. (2010) Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 278, 229-241.
DOI
|
26 |
Polakis, P. (2012) Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 4, a008052.
|
27 |
Ramasamy, K. and Agarwal, R. (2008) Multitargeted therapy of cancer by silymarin. Cancer Lett. 269, 352-362.
DOI
|
28 |
Reya, T. and Clevers, H. (2005) Wnt signalling in stem cells and cancer. Nature 434, 843-850.
DOI
|
29 |
Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014) Cancer statistics, 2014. CA Cancer J. Clin. 64, 9-29.
DOI
|
30 |
Sparks, A. B., Morin, P. J., Vogelstein, B. and Kinzler, K. W. (1998) Mutational analysis of the APC/-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130-1134.
|
31 |
Xie, J., Xiang, D. B., Wang, H., Zhao, C., Chen, J., Xiong, F., Li, T. Y. and Wang, X. L. (2012) Inhibition of Tcf-4 induces apoptosis and enhances chemosensitivity of colon cancer cells. PLoS One 7, e45617.
DOI
|
32 |
Tetsu, O. and McCormick, F. (1999) -catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
DOI
|
33 |
Vaid, M., Prasad, R., Sun, Q. and Katiyar, S. K. (2011) Silymarin targets -catenin signaling in blocking migration/invasion of human melanoma cells. PLoS One 6, e23000.
DOI
|
34 |
Wang, D., Wise, M. L., Li, F. and Dey, M. (2012) Phytochemicals attenuating aberrant activation of -catenin in cancer cells. PLoS One 7, e50508.
DOI
|
35 |
Yang, L. H., Xu, H. T., Han, Y., Li, Q. C., Liu, Y., Zhao, Y., Yang, Z. Q., Dong, Q. Z., Miao, Y., Dai, S. D. and Wang, E. H. (2010) Axin downregulates TCF-4 transcription via -catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells. Mol. Cancer 9, 25.
DOI
|
36 |
Zi, X., Feyes, D. K. and Agarwa, R. (1998) Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDAMB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Clin. Cancer Res. 4, 1055-1064.
|